Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in HKD, Billions.
The item "Change-In-Other-Working-Capital" stands at 0.51 Billion Hong Kong Dollars for the trailing twelve months (TTM) period ending 09/30/2023, the lowest value at least since 09/30/2021, the period currently displayed.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -49.21 percent compared to the value the year prior.
The 1 year change in percent is -49.21.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Change In Other Working Capital | 905,699,262,464.00 |
![]() | Johnson & Johnson - Change In Other Working Capital | 486,508,953,600.00 |
![]() | AbbVie Inc - Change In Other Working Capital | 399,570,305,024.00 |
![]() | Roche Holding AG - Change In Other Working Capital | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Change In Other Working Capital | 280,205,508,085.11 |